ReviewMolecular biology reports2026
Musculoskeletal degeneration and cardiovascular aging: a narrative review of shared mechanobiological pathways.
Review in Molecular biology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aging is characterized by progressive changes in several organ systems, which specifically affects the musculoskeletal and cardiovascular system. Traditionally, recent discoveries have highlighted common mechanical pathways that combine musculoskeletal degeneration with cardiovascular aging. Understanding these mechanisms can provide new insights into integrated prevention and treatment strategies. This narrative overview integrates current evidence of age-related structural and functional changes in the musculoskeletal and cardiovascular system, highlighting mechanical pathways such as YAP/TAZ, Wnt/β-catenin, TGF-β, and integrin signaling. Clinical studies co-degeneration, common risk factors, and testing therapeutic interventions have been critically analyzed to highlight the meaning of translation. Musculoskeletal degeneration manifests as sarcopenia, osteoporosis and arthritis, whereas cardiovascular aging is characterized by vascular sclerosis, myocardial fibrosis, dysfunction of endothelium. Both systems share common mechanisms including low degrees' inflammation, oxidative stress, mitochondrial dysfunction, and impaired chronic inflammation with dysregulated extracellular matrix remodeling, and disorders of chronic inflammation. Clinical evidence shows that musculoskeletal waste promotes cardiovascular degradation and vice versa, contributing to frailty, reduced mobility and increased mortality. Important common risk factors, sedentary lifestyle, metabolic disorders, oxidative stress, and hormonal changes, promote parallel degeneration. Lifestyle changes, targeted drugs, optimized nutrition, and regenerative medicine offer potential to reduce co-degeneration. Connected biological and mechanical pathways link musculoskeletal and cardiovascular aging that requires integrated diagnosis and treatment. Targeting mechanical dysfunction and systemic risk factors can improve resistance and quality of life in older adult. Future research should focus on longitudinal studies, biomarker identification, and personalized interventions to promote healthy aging through interconnected systems.
Indexed as
Identifiers
42217061What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.